Tengion

Miclot joins Tengion

Tuesday, December 6, 2011 09:25 AM

Tengion has named John L. Miclot president and chief executive officer.

More... »


Tengion names Flora to board of directors

Wednesday, September 28, 2011 11:45 AM

Tengion has named Scott Flora to its board of directors. Flora brings to Tengion more than 20 years of experience building and managing successful wound healing and surgical device businesses.  He most recently served as global business unit president of surgical devices at Covidien.

More... »


Jorkasky joins Tengion’s board of directors

Tuesday, August 16, 2011 02:23 PM

Tengion has named Diane Jorkasky, M.D. to its board of directors. Jorkasky recently joined Endo Pharmaceuticals as senior vice president, clinical development and chief medical officer. She was previously chief development and medical officer at Aileron Therapeutics.

More... »

Tengion CEO Nichtberger resigns

Friday, July 1, 2011 10:02 AM

Dr. Steven A. Nichtberger has resigned as president and CEO of Tengion, a regenerative medicine company focused on developing replacement organs and tissues grown from a person’s own cells, according to a report in the Philadelphia Business Journal.

More... »

FDA grants Tengion Orphan Drug designation

Friday, June 10, 2011 11:57 AM

Tengion, based in East Norriton, Penn., said the FDA has granted Orphan Drug designation to the company's Neo-Urinary Conduit, for treatment of bladder dysfunction requiring incontinent urinary diversion. 

More... »

Tengion adds renal experts to R&D advisory panel

Tuesday, March 29, 2011 12:19 PM

Tengion, a company involved in regenerative medicine, announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D., from the Harvard Stem Cell Institute and Giuseppe Remuzzi, M.D., F.R.C.P., from the Mario Negri Institute, to its panel of R&D advisors.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.